Podcast in English
Text size
Bulgarian National Radio © 2024 All Rights Reserved

There are no plans to recall the AstraZeneva vaccine: Bulgarian Drug Agency director

Photo: BGNES

“There are no plans to recall the AstraZeneva vaccine,” said Bulgarian Drug Agency Director Bogdan Kirilov for BNT.

He advised the people vaccinated with a first dose of AstraZeneca who did not have severe adverse effects after the first shot, to wait 84 days and then consider taking the second dose.

“For a vaccine to be recalled there has to be data showing there is a problem with effectiveness, safety and quality, but the vaccine has been approved by the European Medicines Agency. At this stage data shows a positive benefits-risk ratio, the vaccine can be administered and it is, therefore, being administered,” Kirilov added. 



Последвайте ни и в Google News Showcase, за да научите най-важното от деня!
Listen to the daily news from Bulgaria presented in "Bulgaria Today" podcast, available in Spotify.

More from category

Vladimir Malinov

Bulgarian energy minister meets Turkish counterpart in Istanbul

Caretaker Energy Minister Vladimir Malinov is on a working visit to Turkey. Today he will hold talks in Istanbul with his Turkish counterpart, Dr Alparslan Bayraktar, Minister of Energy and Natural Resources. The meeting is on the initiative of..

published on 4/27/24 7:40 AM

Sunny Saturday and Sunday, rain in the mountains

On Saturday, minimum temperatures in the country will be between 5 and 10°C, around 5°C in Sofia. The morning will be sunny. In the afternoon it will be cloudy in the mountains, where rain and snow will fall, and sunny in the east. Maximum temperatures..

published on 4/26/24 7:05 PM
Angel Kunchev

The spread of whooping cough is expected to subside by the end of 2024

An emergency epidemic situation will not be introduced in the country due to the spread of pertussis (whooping cough), as this is not necessary. This was announced by the chief state health inspector, Assoc. Prof. Angel Kunchev...

published on 4/26/24 11:53 AM